Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$127.77 - $221.42 $493,064 - $854,459
3,859 Added 11.93%
36,200 $7.85 Million
Q3 2023

Nov 13, 2023

SELL
$154.67 - $290.89 $1.26 Million - $2.36 Million
-8,118 Reduced 20.06%
32,341 $5.16 Million
Q2 2023

Aug 11, 2023

BUY
$272.48 - $330.23 $191,553 - $232,151
703 Added 1.77%
40,459 $11.7 Million
Q1 2023

May 15, 2023

BUY
$276.36 - $326.03 $636,733 - $751,173
2,304 Added 6.15%
39,756 $12.7 Million
Q4 2022

Feb 14, 2023

BUY
$212.22 - $313.46 $1.31 Million - $1.94 Million
6,175 Added 19.74%
37,452 $11 Million
Q3 2022

Nov 14, 2022

BUY
$224.6 - $281.45 $613,831 - $769,202
2,733 Added 9.57%
31,277 $7.18 Million
Q2 2022

Aug 15, 2022

BUY
$186.4 - $279.02 $586,041 - $877,238
3,144 Added 12.38%
28,544 $6.22 Million
Q1 2022

May 16, 2022

BUY
$194.8 - $275.7 $726,409 - $1.03 Million
3,729 Added 17.21%
25,400 $6.77 Million
Q4 2021

Feb 14, 2022

BUY
$255.32 - $318.29 $4.44 Million - $5.53 Million
17,377 Added 404.68%
21,671 $5.77 Million
Q3 2021

Nov 15, 2021

SELL
$260.36 - $307.27 $78,889 - $93,102
-303 Reduced 6.59%
4,294 $1.22 Million
Q2 2021

Aug 16, 2021

BUY
$225.52 - $304.06 $151,098 - $203,720
670 Added 17.06%
4,597 $1.26 Million
Q1 2021

May 14, 2021

BUY
$235.95 - $293.05 $18,168 - $22,564
77 Added 2.0%
3,927 $1.03 Million
Q4 2020

Feb 16, 2021

BUY
$215.97 - $265.89 $71,486 - $88,009
331 Added 9.41%
3,850 $984,000
Q3 2020

Nov 16, 2020

BUY
$192.55 - $236.59 $51,603 - $63,406
268 Added 8.24%
3,519 $833,000
Q2 2020

Aug 14, 2020

BUY
$159.17 - $224.73 $197,211 - $278,440
1,239 Added 61.58%
3,251 $632,000
Q1 2020

May 15, 2020

BUY
$130.01 - $216.44 $261,580 - $435,477
2,012 New
2,012 $333,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $19.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Capital International Sarl Portfolio

Follow Capital International Sarl and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.